BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18293675)

  • 1. [Macroprolactinemia identification in patients with hyperprolactinemia].
    Sandoval C; González B; Cheng S; Esquenazi Y; Mercado M
    Ginecol Obstet Mex; 2007 Aug; 75(8):459-64. PubMed ID: 18293675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Screening and detection of patients with macroprolactinemia by application of polyethylene glycol precipitation method].
    Chen YJ; Zhou YL; Xu L; Yan J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):187-92. PubMed ID: 24782376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macroprolactinemia: predictability on clinical basis and detection by PEG precipitation with two different immunometric methods.
    Amadori P; Dilberis C; Marcolla A; Pinamonti M; Menapace P; Dal Bosco F
    J Endocrinol Invest; 2003 Feb; 26(2):148-56. PubMed ID: 12739743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of macroprolactinemia in hyperprolactinemia.
    Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies.
    Hattori N
    J Clin Endocrinol Metab; 1996 Feb; 81(2):586-90. PubMed ID: 8636272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
    Shimatsu A; Hattori N
    Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroprolactinemia: new insights in hyperprolactinemia.
    Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
    Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Method of Using Polyethylene Glycol (PEG) Precipitation of Macroprolactin to Detect Genuine Hyperprolactinemia.
    Chen Y; Wang H; Yang W; Jin W; Yu W; Wang W; Zhang K; Song G
    J Clin Lab Anal; 2016 Nov; 30(6):1169-1174. PubMed ID: 27219457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroprolactinemia: the consequences of a laboratory pitfall.
    Toldy E; Löcsei Z; Szabolcs I; Góth MI; Kneffel P; Szöke D; Kovács GL
    Endocrine; 2003 Dec; 22(3):267-73. PubMed ID: 14709800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of PEG precipitation and ultrafiltration treatment for serum macroprolactin in Chinese patients with hyperprolactinemia.
    Ke X; Wang L; Duan L; Yang H; Yin J; Qiu L; Pan H; Gong F; Zhu H
    Clin Chim Acta; 2023 Apr; 544():117358. PubMed ID: 37086942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroprolactinemia Detection by Magnetically Assisted Polyethylene Glycol Precipitation: Potential for Automation.
    Smith T; Stern E; Tan E; Vacic A; Fahie-Wilson M
    J Appl Lab Med; 2020 May; 5(3):494-505. PubMed ID: 32445359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
    Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
    Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method.
    Leslie H; Courtney CH; Bell PM; Hadden DR; McCance DR; Ellis PK; Sheridan B; Atkinson AB
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2743-6. PubMed ID: 11397880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinemia due to big big prolactin is differently detected by commercially available immunoassays.
    Cavaco B; Prazeres S; Santos MA; Sobrinho LG; Leite V
    J Endocrinol Invest; 1999 Mar; 22(3):203-8. PubMed ID: 10219888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
    Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
    Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
    Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
    BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.